Interferon therapy in renal allograft recipients with chronic hepatitis C
Harihara, Y.; Kurooka, Y.; Yanagisawa, T.; Kuzuhara, K.; Otsubo, O.; Kumada, H.
Transplantation Proceedings 26(4): 2075
1994
ISSN/ISBN: 0041-1345 PMID: 8066675 Document Number: 428012
Document emailed within 1 workday
Related Documents
Lewandowska, D.; Durlik, M.; Pazik, J.; Lewandowski, Z.; Lao, M.ła. 2003: The influence of lamivudine therapy on the course of chronic hepatitis B in renal allograft recipients Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 15(88): 367-370Anand, A.C.; Seth, A.K.; Nagpal, A.; Varma, P.P.; Gadela, S.R.; Baliga, K.V.; Dutta, V.; Chopra, G.S. 2004: Initial experience with ribavirin plus glycyrrhizin in renal allograft recipients with chronic hepatitis C Indian Journal of Gastroenterology: Official Journal of the Indian Society of Gastroenterology 23(6): 226-227
Rigby, R.J.; Smillie, A.; Cheung, K.; Robinson, M.F. 1985: Natural killer activity in renal allograft recipients and response to interferon Transplantation Proceedings 17(2): 1682-1684
Dakshinamurty, K.V.; Date, A.; Jacob, C.K.; Kirubakaran, M.G.; Shastry, J.C. 1988: Hepatitis in living-donor renal allograft recipients Transplantation 46(6): 926-927
Peterson, P.K.; Simmons, R.L. 1984: Infectious diseases in renal allograft recipients: new developments in therapy and prevention Transplantation Proceedings 16(4): 1111-1113
Durlik, M.; Gaciong, Z.; Soluch, L.; Walecka-Zielecka, B.; Rancewicz, Z.; Rowińska, D.; Rowiński, W.; Szmidt, J.; Lao, M. 1996: Risk of chronic liver disease in HBsAG and/or anti-HCV-positive renal allograft recipients Transplantation Proceedings 28(1): 50-51
Buturović, J.; Kandus, A.; Malovrh, M.; Bren, A.; Drinovec, J. 1990: Cyclosporine-associated hemolytic uremic syndrome in four renal allograft recipients: resolution without specific therapy Transplantation Proceedings 22(4): 1726-1727
Mels, G.C.; Roffi, L.; Antonelli, G.; Bellati, G.; Pacchetti, S.; Di Nolfo, M.A.; Panizzuti, F.; Moretti, G.; Piperno, A.; Pozzi, M. 1993: Lymphoblastoid interferon in patients with chronic nAnB hepatitis showing relapse during recombinant alpha interferon therapy Progress in Clinical and Biological Research 382: 359-364
Rostaing, L.; Izopet, J.; Baron, E.; Duffaut, M.; Puel, J.; Durand, D. 1995: Treatment of chronic hepatitis C with recombinant alpha 2b interferon in kidney transplant recipients: preliminary results and side effects Transplantation Proceedings 27(1): 948-950
Schvoerer, E.; Kabissa, I.; Cotto, E.; Jouvencel, A-Christine.; Balabaud, C.; De Ledinghen, V.; Couzigou, P.; Quinton, Aé.; Schvoerer, C.; Lafon, M-Edith.; Fleury, Hé.; Bernard, P-Henri. 2002: Lamivudine therapy of chronic hepatitis B in three groups of patients: non transplanted patients, liver recipients, and kidney recipients Gastroenterologie Clinique et Biologique 26(1): 62-66
Younossi, Z.M.; Braun, W.E.; Protiva, D.A.; Gifford, R.W.; Straffon, R.A. 1999: Chronic viral hepatitis in renal transplant recipients with allografts functioning for more than 20 years Transplantation 67(2): 272-275
Jordan, S.C.; Quartel, A.W.; Czer, L.S.; Admon, D.; Chen, G.; Fishbein, M.C.; Schwieger, J.; Steiner, R.W.; Davis, C.; Tyan, D.B. 1998: Posttransplant therapy using high-dose human immunoglobulin (intravenous gammaglobulin) to control acute humoral rejection in renal and cardiac allograft recipients and potential mechanism of action Transplantation 66(6): 800-805
Górriz, J.L.; Pallardó, L.M.; Sarrión, A.; Sánchez, J.; Rochera, A. 1995: Hepatitis C virus infection in renal transplant recipients: prognostic significance of chronic transaminase elevation Transplantation Proceedings 27(4): 2250-2251
Sturgiss, S.N.; Davison, J.M. 1991: Perinatal outcome in renal allograft recipients: prognostic significance of hypertension and renal function before and during pregnancy Obstetrics and Gynecology 78(4): 573-577
Hrycewycz, N.; Sandres, K.; Barange, K.; Pascal, J.P.; Izopet, J.; Payen, J.L. 2001: Eradication of hepatitis C virus after 3 months of interferon and ribavirin treatment in an a interferon non-responder patient with chronic hepatitis C Gastroenterologie Clinique et Biologique 25(11): 1041-1042
Arase, Y. 2006: Side effects of interferon therapy for chronic hepatitis C Nihon Rinsho. Japanese Journal of Clinical Medicine 64(7): 1363-1367
Fujisawa, T.; Inui, A.; Komatsu, H.; Miyagawa, Y.; Onoue, M. 1998: Interferon-alpha therapy for children with chronic hepatitis C Zhonghua Minguo Xiao Er Ke Yi Xue Hui Za Zhi Zhonghua Minguo Xiao Er Ke Yi Xue Hui 39(3): 146-149
Hussain, Z.; Naqvi, R.; Hashmi, A.; Hafiz, S.; Naqvi, A.; Rizvi, A. 1996: Tuberculosis in renal allograft recipients Transplantation Proceedings 28(3): 1516-1517
Kato, M.; Yuki, N.; Kaneko, A.; Yamamoto, K.; Kasahara, A.; Masuzawa, M.; Hayashi, N. 2001: Two-step interferon rebound therapy for refractory chronic hepatitis C Nihon Rinsho. Japanese Journal of Clinical Medicine 59(7): 1315-1319
Koff, R.S. 1996: Therapy in chronic hepatitis C: say goodbye to the 6-month interferon regimen American Journal of Gastroenterology 91(10): 2072-2074